Imad A. Tabbara

3.4k total citations · 1 hit paper
65 papers, 2.5k citations indexed

About

Imad A. Tabbara is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Imad A. Tabbara has authored 65 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Hematology, 25 papers in Oncology and 20 papers in Molecular Biology. Recurrent topics in Imad A. Tabbara's work include Acute Myeloid Leukemia Research (16 papers), Hematopoietic Stem Cell Transplantation (12 papers) and Neutropenia and Cancer Infections (10 papers). Imad A. Tabbara is often cited by papers focused on Acute Myeloid Leukemia Research (16 papers), Hematopoietic Stem Cell Transplantation (12 papers) and Neutropenia and Cancer Infections (10 papers). Imad A. Tabbara collaborates with scholars based in United States, Egypt and New Zealand. Imad A. Tabbara's co-authors include Samah Nassereddine, Morgan E. Stewart, Howard Ozer, Gary H. Lyman, Vincent J. Picozzi, David H. Johnson, John Grous, William J. Gradishar, Ronald G. Stoller and Roy E. Smith and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Imad A. Tabbara

63 papers receiving 2.4k citations

Hit Papers

Reduction by Granulocyte Colony-Stimulating Factor of Fev... 1991 2026 2002 2014 1991 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer
    1991 1.1k citations Imad A. Tabbara et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Imad A. Tabbara United States 21 1.4k 761 499 462 271 65 2.5k
Kai Hübel Germany 23 935 0.6× 847 1.1× 387 0.8× 230 0.5× 589 2.2× 83 2.1k
Belinda R. Avalos United States 23 779 0.5× 1.0k 1.3× 387 0.8× 307 0.7× 709 2.6× 100 2.1k
Yoshiyuki Kosaka Japan 26 514 0.4× 1.3k 1.7× 792 1.6× 249 0.5× 476 1.8× 146 2.6k
Michael Rytting United States 31 1.3k 0.9× 2.1k 2.7× 1.1k 2.3× 207 0.4× 312 1.2× 96 4.2k
Gordon L. Phillips United States 26 1.0k 0.7× 1.6k 2.0× 476 1.0× 291 0.6× 643 2.4× 87 3.8k
Carmen Sílvia Passos Lima Brazil 25 513 0.4× 600 0.8× 991 2.0× 243 0.5× 173 0.6× 191 2.3k
Valerie P. Castle United States 32 822 0.6× 843 1.1× 1.9k 3.8× 252 0.5× 358 1.3× 75 4.2k
Deepa Bhojwani United States 31 957 0.7× 1.1k 1.5× 731 1.5× 195 0.4× 308 1.1× 111 3.5k
G.J. Ossenkoppele Netherlands 34 1.1k 0.8× 1.6k 2.1× 783 1.6× 123 0.3× 607 2.2× 84 3.3k
David K. Kalwinsky United States 28 544 0.4× 1.6k 2.1× 743 1.5× 210 0.5× 178 0.7× 70 3.0k

Countries citing papers authored by Imad A. Tabbara

Since Specialization
Citations

This map shows the geographic impact of Imad A. Tabbara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Imad A. Tabbara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Imad A. Tabbara more than expected).

Fields of papers citing papers by Imad A. Tabbara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Imad A. Tabbara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Imad A. Tabbara. The network helps show where Imad A. Tabbara may publish in the future.

Co-authorship network of co-authors of Imad A. Tabbara

This figure shows the co-authorship network connecting the top 25 collaborators of Imad A. Tabbara. A scholar is included among the top collaborators of Imad A. Tabbara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Imad A. Tabbara. Imad A. Tabbara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tabbara, Imad A., et al.. (2025). Bruton Tyrosine Kinase Degraders. American Journal of Clinical Oncology. 48(5). 257–261. 1 indexed citations
2.
Aggarwal, Anita, et al.. (2019). Chronic Myeloid Leukemia as Secondary Malignancy Following the Treatment of Hodgkin Lymphoma: A Case Series. Anticancer Research. 39(8). 4333–4335. 7 indexed citations
3.
Mascarenhas, John, Hilary Blacklock, Aaron T. Gerds, et al.. (2018). Outcomes of patients with myelofibrosis treated with compassionate use pacritinib: a sponsor-independent international study. Annals of Hematology. 97(8). 1369–1374. 9 indexed citations
4.
Tabbara, Imad A., et al.. (2018). Directed Therapies in Anaplastic Lymphoma Kinase-rearranged Non-small Cell Lung Cancer. Anticancer Research. 38(9). 4969–4975. 13 indexed citations
5.
Nassereddine, Samah, et al.. (2017). PD-1 signaling and inhibition in AML and MDS. Annals of Hematology. 96(9). 1441–1448. 34 indexed citations
6.
Wang, James, Tanya M. Spektor, Jacob D. Bitran, et al.. (2017). Safety of BTZ retreatment for patients with low-grade peripheral neuropathy during the initial treatment. Supportive Care in Cancer. 25(10). 3217–3224. 2 indexed citations
7.
Nassereddine, Samah, et al.. (2017). Acute Graft Versus Host Disease: A Comprehensive Review. Anticancer Research. 37(4). 1547–1555. 123 indexed citations
8.
Tabbara, Imad A., et al.. (2016). Anaemia with inflammation responding to lenalidomide. BMJ Case Reports. 2016. bcr2016217055–bcr2016217055.
9.
Patel, Nihar, et al.. (2014). Complications of Allogeneic Hematopoietic Stem Cell Transplantation. Cancer Investigation. 32(7). 349–362. 62 indexed citations
10.
Vacirca, Jeffrey, et al.. (2013). Bendamustine combined with rituximab for patients with relapsed or refractory diffuse large B cell lymphoma. Annals of Hematology. 93(3). 403–409. 72 indexed citations
11.
Bose, Sumit Kumar, et al.. (2011). Lymphocyte-predominant Hodgkin Disease. American Journal of Clinical Oncology. 36(1). 91–96. 4 indexed citations
12.
Ghanem, Hady, et al.. (2011). Prognostic implications of genetic aberrations in acute myelogenous leukemia with normal cytogenetics. American Journal of Hematology. 87(1). 69–77. 20 indexed citations
13.
Pollack, Seth M., T O'Connor, Jana G. Hashash, & Imad A. Tabbara. (2009). Nonmyeloablative and Reduced-Intensity Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation. American Journal of Clinical Oncology. 32(6). 618–628. 23 indexed citations
14.
Hashash, Jana G., et al.. (2007). Dendritic cell neoplasms: An overview. American Journal of Hematology. 82(10). 924–928. 85 indexed citations
15.
Tabbara, Imad A., et al.. (2002). Allogeneic Hematopoietic Stem Cell Transplantation. Archives of Internal Medicine. 162(14). 1558–1558. 136 indexed citations
16.
17.
Tabbara, Imad A.. (1996). Allogeneic Bone Marrow Transplantation. Southern Medical Journal. 89(9). 857–868. 13 indexed citations
18.
Tabbara, Imad A.. (1993). Erythropoietin. Biology and clinical applications. Archives of Internal Medicine. 153(3). 298–304. 25 indexed citations
19.
Tabbara, Imad A.. (1993). Granulocyte Colony-Stimulating Factor. Southern Medical Journal. 86(3). 350–355. 17 indexed citations
20.
Tabbara, Imad A.. (1992). Hemolytic anemias: Diagnosis and Management. Medical Clinics of North America. 76(3). 649–668. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kai Hübel Breakdown of academic impact, for papers by Belinda R. Avalos Breakdown of academic impact, for papers by Yoshiyuki Kosaka Breakdown of academic impact, for papers by Michael Rytting Breakdown of academic impact, for papers by Gordon L. Phillips Breakdown of academic impact, for papers by Carmen Sílvia Passos Lima Breakdown of academic impact, for papers by Valerie P. Castle Breakdown of academic impact, for papers by Deepa Bhojwani Breakdown of academic impact, for papers by G.J. Ossenkoppele Breakdown of academic impact, for papers by David K. Kalwinsky
Rankless by CCL
2026